ACGT

ACGT aims to present the 'next-step' in cancer research and fill-in the technological gaps of clinical trials targeting two forms of cancer: breast cancer and paediatric nephroblastoma. ACGT will develop a Biomedical GRID infrastructure supporting seamless mediation services for sharing clinical and genomic expertise. It will help to identify quicker and more efficiently the characteristics that determine what form of treatment best suits which patient.

ACGT aims to provide researchers and patients with the best means and resources to fight cancer. ACGT is working towards the rapid identification of cancer profiles and best treatments. The ACGT project will:

  • Define common standards of data storage at each level of investigation.
  • Develop new ontologies for cross-referencing terms and their biological contexts.
  • Implement a bio-medical GRID infrastructure offering seamless mediation services for sharing data and dataprocessing.

ACGT will therefore deliver a unifying infrastructure allowing cancer researchers to share their data and to benefit from the innovative informatics tools that are being developed by other researchers.

For further information, please visit:
http://www.eu-acgt.org

Project co-ordinator:
ERCIM EEIG

Partners:

  • ERCIM EEIG - Institut National de Recherche en Informatique et en Automatique - Healthgrid (FR)
  • Foundation for Research and Technology Hellas - A. Persidis & SIA O.E. - University of Crete - Institute of Communications and Computer Systems (GR)
  • University van Amsterdam - Philips Electronics Nederland B.V. (NL)
  • Association Hospitaliere de Bruxelles – Centre Hospitalier Universitaire Bordet – Custodix - Facultes Universitaires Notre-Dame de la Paix (BE)
  • Institut Suisse de Bioinformatique (CH)
  • Lunds Universitet (SE)
  • Universidad de Malaga - Universidad Politechnica de Madrid (ES)
  • Fraunhofer-Gesellschaft zur Foerderung der angewandten Forschung - Unisersitaet Hannover - Universitaet des Saarland - Universitaet Hamburg (DE)
  • Instytut Chemii Biooganicznej pan w Poznaniu (PL)
  • S.C. SIVECO ROMANIA SA (RO)
  • The Chancellor, Masters and Scholars of the University of Oxford (UK)
  • Hokkaido University (JP)
  • Istituto Europeo di Oncologia s.r.l. (IT)

Timetable: from 02/06 - to 01/10

Total cost: € 16. 747.206

EC funding: € 11. 887.000

Instrument: Integrated Project

Project Identifier: IST-2004-026996

Most Popular Now

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...